MedPath

Biodiversity Interventions for Assisted Living Centers

Not Applicable
Active, not recruiting
Conditions
Microbial Colonization
Nature, Human
Autism Spectrum Disorder
Visual Impairment
Well-Being, Psychological
Immune System and Related Disorders
Interventions
Other: Rewilding
Registration Number
NCT06390683
Lead Sponsor
Natural Resources Institute Finland
Brief Summary

Biodiversity is essential for nature and human well-being. Land use has reduced biodiversity in cities, which weakens the functionality of the urban ecosystems and the well-being of citizens. This may also increase the risk of immune-mediated disorders among urban dwellers.

In Biodiversity interventions for assisted living centers (BIWE 2), microbial biodiversity interventions are performed to increase biodiversity in urban housing units for people with autism spectrum disorder, disabled people and elderly. Results from the intervention trials are combined with publicly available land cover and ecological data. These are analyzed from the viewpoint of shifts in ecosystems and human well-being and immune regulation, ecological quality, and urban planning.

The investigators set up an intervention study in which yards of the housing units are rewilded with diverse vegetation and decaying deadwood and plant residuals. The investigators aim to evaluate the effect of rewilding, and yard management practices on commensal microbiome, cortisol levels and well-being and salivary cytokine levels, and gene pathways.

Detailed Description

Our specific aims are:

To assess if rewilding diversifies health-associated skin microbiota and is associated with salivary cytokine levels, gene pathways, cortisol levels and commensal microbiota.

Assess whether there are patterns in the microbiome associated with the salivary cytokine levels and hair cortisol levels.

Assess whether rewilding affects health and psychological measures. The investigators will recruit approximately 36 study subjects living in assisted housing units in urban areas and aged between 18-82.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Person lives in assisted living center
Exclusion Criteria
  • Immunosuppressive medications
  • Immune deficiencies
  • a disease affecting immune response (colitis ulcerosa, rheumatoid arthritis, Crohn's disease, diabetes)
  • cancer diagnosis within the last year or on-going cancer treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
RewildingRewildingYards of the housing units are rewilded with vegetation, deadwood and plant residuals.
Primary Outcome Measures
NameTimeMethod
Skin GammaproteobacteriaBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year

Change in skin gammaproteobacterial diversity

Secondary Outcome Measures
NameTimeMethod
Saliva gene pathwaysBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year

Changes in salivary gene pathways are analyzed with shotgun sequencing.

Salivary cytokinesBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year

Interleukin-6 and -10 measured from saliva

Saliva microbiotaBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year

Changes in saliva microbiota are analyzed with shotgun sequencing.

Cortisol levelsBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year

Cortisol levels measured from hair samples

Warwick-Edinburgh Mental Wellbeing ScaleBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year

Increase in Warwick-Edinburhg Mental Wellbeing scale score during the study period that indicates better mental well-being. Minimum 14, maximum 70.

Perceived Stress ScaleBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year

Decrease in perceived stress scale score during the study period that indicates lower perceived stress levels. Minimum 0, maximum 40.

Nature Relatedness ScaleBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year

Increase in Nature Relatedness scale during the study period that indicates stronger sense of connectedness to nature. Minimum 6, maximum 30.

Skin bacteriaBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year

Changes in skin bacteria are analyzed with Illumina 16s rRNA sequencing.

Depression ScaleBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year

Decrease in depression scale score during the study period that indicates lower levels of depression symptoms. Minimum 0, maximum 70.

Changes in nature contactsBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year

Increase in time that study subjects are in contact with nature during the study period.

Infectious diseasesBaseline, 3 month, 1 year, 2 year, 3 year, 4 year, 5 year

Infectious diseases are recorded with questionnaires.

Trial Locations

Locations (1)

Natural Resources Institute Finland

🇫🇮

Helsinki, Uusimaa, Finland

© Copyright 2025. All Rights Reserved by MedPath